A rapid and feasible tool for clinical decision making in community-dwelling patients with COVID-19 and those admitted to emergency departments: the Braden-LDH-HorowITZ Assessment—BLITZ

Abstract

There is no univocal standardized strategy to predict outcomes and stratify risk of SARS-CoV-2 infected patients, notably in emergency departments. Our aim is to develop an accurate indicator of adverse outcomes based on a retrospective analysis of a COVID-19 database established at the Emergency Department (ED) of a North-Italian hospital during the first wave of SARS-CoV-2 infection. Laboratory, clinical, psychosocial and functional characteristics including those obtained from the Braden Scale—a standardized scale to quantify the risk of pressure sores which takes into account aspects of sensory perception, activity, mobility and nutrition—from the records of 117 consecutive patients with swab-positive COVID-19 disease admitted to the Emergency Medicine ward between March 1, 2020 and April 15, 2020 were included in the analysis. Adverse outcomes included admission to the Intensive Care Unit (ICU) and in-hospital death. Among the parameters collected, the highest cutoff sensitivity and specificity scores to best predict adverse outcomes were displayed by lactate dehydrogenase (LDH) blood value at admission > 439 U/L, Horowitz Index (P/F Ratio) < 257 and Braden score < 18. The estimation power reached 93.6%. We named the assessment BLITZ (Braden-LDH-HorowITZ). Despite the retrospective and preliminary nature of the data, a multidimensional tool to assess overall functions, not chronological age, produced the highest prediction power for poor outcomes in relation to SARS-CoV-2 infection. Further analyses are now needed to establish meaningful correlations between ventilation therapies and multidimensional frailty as assessed by ad-hoc validated and standardized tools.

Introduction

The current COVID-19 pandemic has highest fatality rates among the older generations and is exhausting world economies and solidarity [1]. Indeed, vast literature is now available regarding the infection and protection mechanisms with respect to the Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2). However, it is unclear how long protective immunity lasts and what are safe therapy and immunization protocols for this novel infection [2]. Especially until these critical questions are solved, and in light of the lack of resilience of already overburdened health care systems that cannot offer sufficient and adequate respiratory support and intensive care, a reliable patient’s risk stratification and triaging for clinical decision making represents currently the number one healthcare priority in real life [3]. Nevertheless, no standard of care is available to date [4]. In addition, social distancing measures are having a strongly detrimental impact on physical and mental health [5]. Therefore, protecting those at most risk of dying from COVID-19 while relaxing the strictures on others provides a way forward in the SARS-CoV-2 epidemic. A coherent risk stratification algorithm is urgently needed even in the presence of effective vaccination, given the virus is unlikely to disappear in the foreseeable future [6]. Emerging evidence throughout the course of the pandemic has shown associations of age, sex, certain comorbidities, smoking habit, ethnicity, and obesity with adverse COVID-19 outcomes such as hospital admission or death [7, 8]. However, the large heterogeneity especially of the older population hinders the univocal approach to triaging so far.

The aim of the present analysis was to identify indicators of adverse outcomes of COVID-19 using the database of the Emergency Department (ED) of a North-Italian hospital.

Methods

Records from 117 consecutive patients admitted to the Emergency Room (ER) of Pietra Ligure Santa Corona Hospital from March 1st to April 15th 2020 and identified as COVID-19-positive in the presence of clinical symptoms and by a positive real-time reverse transcriptase-polymerase chain reaction (RT-PCR) nasopharyngeal swab test as well as by radiological diagnosis and clinical criteria were included in this retrospective analysis.

All patients were transferred from the ER to the ED of the same hospital and all of them were admitted to ward. Laboratory, clinical, psychosocial and functional characteristics including those obtained from the Conley Scale—a six-item scale that aims to identify patients at risk of falling—and the Braden Scale—a standardized scale to quantify the risk of pressure sores which takes into account aspects of sensory perception, activity, mobility and nutrition—were performed on admission in all patients. No exclusion criteria were applied to the datasets and no “Do Not Resuscitate” (DNR) patient was present in the sample analyzed. Ethical approval was not required due to the retrospective nature of the work and the entailed use of anonymized routinely collected data. Data analysis approval was obtained by the local governance.

Statistical analysis

General characteristics were reported as proportions and min, max, median, quartiles, mean as well as standard deviation for categorical and continuous variables, respectively. For the above cited purpose of the investigation, three disease adverse outcomes were chosen on a first step: admission on ICU, invasive ventilation [IV—ventilation forms requiring intubation including invasive continuous positive airway pressure (CPAP) therapy and biphasic positive airway pressure (BPAP)] as well as in-hospital death. Secondly, the significance of the association between each of the 117 independent variables and each of the 3 selected outcomes was tested. To do so, Chi-square testing or Fisher exact test were used in 2 × 2 contingency tables to evaluate associations (alpha = 0.05). Numeric variables were transformed into binary values (≥ median = 1, < median = 0). To test the weight of a more simplified outcome with high utilization potential across settings technology, IV was excluded and in-hospital death OR admission to ICU were chosen as composite outcome. Third and lastly, the variables found to be associated with either admission on ICU, IV or in-hospital death were tested on the new composite outcome (death OR ICU) followed by dichotomic transformation and multiple logistic regression analysis for those showing significant associations. For each of the independent numerical variables, a ROC analysis was carried out to search for the best cutoff. To do so, the risk of outcome within the quartiles of the variables after binary conversion and best cutoff value identification as a threshold for each was analyzed.

Missing data were replaced by statistical estimates with Mode as imputation value. A comparison with the next neighbor value technique (Last Observation Carried Forward) after list-wise deletion was carried out to confirm the results [9]. To estimate the risks associated to the outcome of interest, a model equation for each of the combinations of the presence/absence of each of the predictive variables was applied. Two-sided alternatives with a significance level of alpha = 0.05 were considered for all the tests. XLSTAT software was used.

Results

Study population

As reported in Table 1, data from 117 patients admitted consecutively to the emergency ward between March 1, 2020 and April 15, 2020 (70 men, mean age 73.1 ± 14.4 years) were considered for this analysis. The emergency percentage of discharges, deaths and ICU admissions was, respectively, 67.5%, 32.4%, 14.5%, with an average length of stay of 14.6 ± 14.9 days.

Table 1.

Characteristics of the sample

	N (total 117)	%	Mean (DS)	Median	Min–max
Female	47	40.1
Male	70	59.8
Age			73.1 (14.4)	77	41–99
Discharged	79	67.5
Deceased	38	32.4
Length of hospital stay			14.6 (14.9)	8
Admitted to ICU	17	14.5

The demographic, clinical and laboratory characteristics of datasets from the 117 consecutive patients admitted to the ER are reported in Table 2. All laboratory parameters considered in the present work were collected in the ED setting. Data entry was performed by a single attending physician blinded to the study procedures and protocol.

Table 2.

Demographic, clinical and laboratory variables associated with outcomes

Variables	N	Best cut-off	Sens (best cutoff)	Spec (best cutoff)	p value
Age	117	> 84	38.0%	80.3%	0.220
Smoke (past)	30		22.2%	47.6%	0.106
Social distancing—R (above 1 m)	115		33.3%	77.6%	0.192
CHD	117		8.0%	79.1%	0.056
Overweight	82		28.6%	93.6%	0.007
Dementia	117		30.0%	79.1%	0.259
Number of drugs	115	≥  6	44.9%	80.3%	0.207
Not 100% self-sufficient	115		20.8%	83.6%	0.546
Confined in bed	115		22.9%	91.0%	0.038
Fever	117		78.0%	26.9%	0.547
Cough	117		34.0%	59.7%	0.487
Dyspnea	117		72.0%	41.8%	0.124
Tachypnoea	107		56.3%	76.3%	0.001
Cyanosis	106		21.3%	96.6%	0.004
Braden total	101	< 18	84.8%	63.6%	0.000
PO2	54	< 54.4	70.0%	88.2%	0.000
HCO3	37	< 23.0	78.6%	78.3%	0.010
Lactate	49	≥ 1.3	70.0%	72.4%	0.003
P/F	76	< 257	74.3%	70,7%	0.000
SpO2%	102	< 95	85.7%	51.7%	0.010
PCR	112	≥ 89.8	68.8%	70.3%	0.000
PCT	90	≥ 0.18	66.7%	76.5%	0.000
Fibrinogen	103	< 511	51.2%	68.9%	0.182
LDH	97	≥ 439	61.0%	87.5%	0.000
AST	95	≥ 44	61.0%	74.1%	0.004
Creat	111	≥ 1.57	33.3%	84.1%	0.031
CPK	105	≥ 84	83.3%	43.9%	0.003
CPAP	117		58.0%	79.1%	0.000

CHD, coronary heart disease; PCR, polymerase chain reaction; PCT, procalcitonin; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; CPK, creatine phosphokinase; CPAP, continuous positive airway pressure

As described in the “Statistical analysis”, variables identified were associated with at least one of the three outcomes originally considered (death, ICU, IV). Table 2 shows also the association of the best cutoff variables with the composite in-hospital death OR ICU admission outcome (in brackets the best cutoffs identified for numerical variables, with ROC analysis).

As displayed in Table 3, three variables (Braden score < 18, LDH≥ 439 U/L and P/F < 257) were identified in the multiple logistic regression analysis as significantly associated with the composite outcome (Table 3). The three-item indicator was named Braden-LDH-HorowITZ (BLITZ) assessment.

Table 3.

Composite outcome-identified variables of the BLITZ estimated by multiple logistic regression

Source	Beta coeff	Standard error	P value	Odds ratio	OR 95% CI lower	OR 95% CI upper
Intercept	− 2192	0.423	0.316
BRADEN < 18	1358	0.502	0.007	3.888	1.453	10.405
LDH ≥ 439	2261	0.548	< 0.0001	9.593	3.278	28.070
P/F < 257	1258	0.480	0.008	3.517	1.373	9.010

The mathematical algorithm used to calculate BLITZ is as follows:

Prob (ICU OR Death) = 1/(1 + exp (−k))

k = −2.192 + 1.358*(1 if BRADEN ≥ 18; 0 if BRADEN < 18) + 2.261*(1 if LDH ≥ 439; 0 if LDH < 439) + 1.258*(1 if PaO2/FiO2 < 257; 0 if PaO2/FiO2 ≥ 257).

with −2.192 being the constant; 1.358; 2.261; 1.258 being the β-coefficients from logistic regression for the respective investigated factors. Starting from the logistics equation, we proceeded to calculate the risks (probability) of adverse outcome (ICU or death). The risk for adverse outcomes (ICU OR death) with a scoring from one to three, with relevant differences among relative weight of each item, is presented in Table 4.

Table 4.

Estimate of the risk of adverse outcome for the different combinations of the 3 risk factors included in BLITZ (1 = yes, 0 = no)

Discussion

In this retrospective analysis of a real-world sample of COVID-19 patients admitted to the ED, we disclosed a significant association between a feasible, rapid BLITZ assessment including Braden value below 18, blood LDH concentration above 439 U/L as well as a P/F below 257 and adverse outcomes including death and ICU admission. The BLITZ-parameters showed good discriminatory power and accuracy in predicting the relevant endpoints chosen irrespective of chronological age. To date, there is no single prognostic or therapeutic algorithm able to univocally guide clinical decisions during the pandemic phases preceding and accompanying the vaccination [10]. This lack, mainly driven by the focus of existing stratification tools exclusively on chronological age, organ function and morbidity, hinders the effective triaging with advancing age. Indeed, there is mounting evidence that multidimensional frailty beyond chronological age and organ specific function is a major driver of outcomes and life trajectories after SARS-CoV-2 infection [2, 11]. Accordingly, a number of scores and early warning prognostic tools [12–16] have been recently developed to determine the risk of death in the ED setting. However, within this frame, BLITZ profiles itself through its highest clinimetric properties and inclusion of social and functional aspects addressed by the Braden scale. This underlines the need of a paradigm shift towards the attention for person-centered factors beyond-organ medicine also in urgent settings [10, 17], where the feasibility of multidimensional prognostic tools based on more comprehensive assessments has been demonstrated [17].

The paradigm shift suggested here is that BLITZ offers a feasible, multidimensional way—even though far from a comprehensive assessment-based prognostic tool—to capture person-centered risk of COVID-19-related poor outcomes beyond infection parameters. This is highly relevant for clinical practice as, due to the accelerating expansion in number of old and very old persons, a progressively larger percentage of the hospitalized patients are older and multimorbid; reliable, feasible risk indicators taking into account the overall functions of the person beyond illnesses and age, applicable across a wide range of healthcare settings and not requiring high-performance medicine, are urgently needed. On the contrary, advanced chronological age and multimorbidity are currently given highest priority for triaging during the present pandemic [8]. However, in our analysis, chronological age does not appear to play a major role for poor outcome prediction. Interestingly, among the several variables included in the analysis, those captured by the Braden Scale have reached highest clinimetric threshold (Table 3). The scale is feasible, being performed in few minutes by ED nurses. The Braden scale addresses domains beyond-organ function and includes functional, cognitive and nutritional aspects that are typically known to influence patients’ trajectories during and after hospitalization [18, 19]. Our observation is in line with recent studies showing a critical role of frailty and functional status in determining COVID-19-related trajectories [2, 11, 12, 20–25].

However, neither is frailty consistently included among potential stratification strategies, nor it is systematically assessed in clinical routine, especially in emergency settings. A decisive instrument to disentangle complexity of clinical pictures in advanced age is the comprehensive geriatric assessment (CGA) [26, 27]. A metanalysis of 29 randomized controlled trials conducted in over 14,000 older patients have shown that the CGA is highly effective in improving diagnosis and management [28]. Recent studies employing CGA-based innovative, feasible tools for the assessment of multidimensional, individualized prognosis clearly showed that the latter disclose critical factors for trajectories which go beyond organ-center medicine and chronological age [29–31] and apply also during the ongoing pandemic [11, 23]. Of note, in our analysis the Braden scale but not the Conley scale—which addresses physical factors only—reached and surpassed the predictive power of the P/F or of the LDH levels, supporting the knowledge that functions escaping diagnostics in usual care influence the ability to thrive in advanced age. For instance, nutrition is known as an essential actor of patient’s recovery and resistance against bacterial and viral infections [32]. As other factors other than an approximative estimation of frailty might substantially influence disease course, like resiliency, nutritional status, polypharmacy and social condition, the use of structured prognostic instruments appears to be highly recommended to avoid vague “clinical reasonableness”, ageism and inadequate management. Simple and reliable tools for the estimation of the prognosis of the older patients are needed to tailor clinical management of older patients.

Although the analysis conveys the strengths of high accuracy of the assessment as well as clear feasibility and real-life application in a catchment area of over 42,000 patients per year during the pandemic, some limitations must be acknowledged, first, the retrospective nature of the analysis of a relatively sample of data. However, the stratification advantage of a multidimensional approach was given highest priority at this stage to provide emergency physicians with a rapid tool for enabling beyond-organ urgent clinical decisions and tailored interventions. A further limitation of the present analysis is that it has been performed after ventilation allocation. However, the strong power of BLITZ, showing that a pathologic Braden score almost doubles the risk of poor outcomes compared to the largely accepted parameters LDH and Horowitz index, suggests the likelihood for generalizability to different allocation phases as well as to larger populations and more settings.

Conclusion

In conclusion, our analysis shows that the BLITZ model, which includes P/F, LDH and the Braden scale as a measure of overall status of the person, but not chronological age, is able to predict with highest accuracy the probability of patients to suffer from the main COVID-19-related adverse outcomes such as admission to ICU and death.

Further prospective investigations are needed to assess whether this prediction model can be validated in larger cohorts in emergency as well as in other settings.

Declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this study, at the beginning of the COVID pandemic, formal written consent was not asked.

Animal and human rights

This study is based on data retrieved at patients’ admission at the beginning of the pandemic. The analyses were performed retrospectively.

Informed consent

For this type of study, formal consent is not required.